Medicina · Nov 17, 2026
Mortality and In-Hospital Costs After Surgical Treatment of Periprosthetic Femoral Fractures Following Hip Arthroplasty: A Retrospective Single-Centre Cohort Study
By Sarıaslan AY, Okur KT, Bozkurt S et al.
Background and Objectives: Periprosthetic femoral fracture (PFF) after hip arthroplasty carries a high mortality rate and a substantial economic burden. National databases have modelled the determinants of hospital cost but cover the index admission alone, without post-discharge survival or an adjudicated fracture classification. We assessed the contributions of patient factors, fracture pattern, and surgical strategy to both outcomes, analysed separately, within a single cohort. Materials and Methods: We retrospectively analysed 74 consecutive patients treated surgically for a PFF at one tertiary centre between September 2017 and December 2023. All-cause mortality, the primary endpoint, was examined by Cox regression, with the Vancouver pattern and the surgical strategy entered as adjusted exposures, separately and together; in-hospital cost, the secondary endpoint, was modelled by gamma regression, with and without length of stay. Results: The mean age was 77.5 years. Forty-two patients (56.8%) died; median survival was 20.8 months and the Kaplan–Meier one-year mortality was 36.8%. Age (adjusted HR 1.06 per year, 95% CI 1.02–1.09, p = 0.001) and ASA class (adjusted HR 3.00 per grade, 1.30–6.96, p = 0.010) were independently associated with mortality, whereas an unstable-stem pattern was not (adjusted HR 0.95, 0.47–1.91). For revision versus osteosynthesis, the hazard was not proportional over time, so the averaged hazard ratio (1.67, 0.74–3.74) did not summarise the association, and exploratory period-specific estimates rested on few events; with only 15 revision procedures, comparisons between surgical strategies were imprecise. Cost was independently associated with ASA class (cost ratio 2.12, 1.44–3.11, p < 0.001) and revision surgery (1.98, 1.34–2.94, p < 0.001), with the latter attenuating to 1.53 (1.08–2.18) once length of stay was added; the revision estimate was robust to alternative distributional assumptions and to the exclusion of influential observations, whereas the magnitude of the ASA estimate depended on a few high-cost patients. Conclusions: Age and ASA class were associated with mortality, whereas ASA class, length of stay, and revision surgery were associated with in-hospital cost. Whether survival differs between revision and osteosynthesis could not be determined, because only 15 patients underwent revision, the hazard was time-varying, and allocation was subject to confounding by indication; the absence of a statistically significant difference does not indicate comparable survival. Within the limits of an observational cohort subject to confounding by indication, these associations support combining patient-based prognostic assessment with fracture-based surgical planning.